Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial

A. Tomaschitz; A. Fahrleitner-Pammer; B. Pieske; N. Verheyen; K. Amrein; E. Ritz; K. Kienreich; J.H. Horina; A. Schmidt; E. Kraigher-Krainer; C. Colantonio; A. Meinitzer; S. Pilz

doi:10.1186/1472-6823-12-19

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial

A. Tomaschitz, A. Fahrleitner-Pammer, B. Pieske, N. Verheyen, K. Amrein, E. Ritz, K. Kienreich, J.H. Horina, A. Schmidt, E. Kraigher-Krainer, C. Colantonio, A. Meinitzer, S. Pilz

Epidemiology and Data Science

Research output: Contribution to journal › Article › Academic › peer-review

69 Downloads (Pure)

Original language	Undefined/Unknown
Article number	19
Journal	BMC Endocrine Disorders
Volume	12
DOIs	https://doi.org/10.1186/1472-6823-12-19
Publication status	Published - 2012

Access to Document

10.1186/1472-6823-12-19

300514Final published version, 830 KB

Cite this

Tomaschitz, A., Fahrleitner-Pammer, A., Pieske, B., Verheyen, N., Amrein, K., Ritz, E., Kienreich, K., Horina, J. H., Schmidt, A., Kraigher-Krainer, E., Colantonio, C., Meinitzer, A., & Pilz, S. (2012). Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial. BMC Endocrine Disorders, 12, [19]. https://doi.org/10.1186/1472-6823-12-19

Tomaschitz, A. ; Fahrleitner-Pammer, A. ; Pieske, B. ; Verheyen, N. ; Amrein, K. ; Ritz, E. ; Kienreich, K. ; Horina, J.H. ; Schmidt, A. ; Kraigher-Krainer, E. ; Colantonio, C. ; Meinitzer, A. ; Pilz, S. / Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial. In: BMC Endocrine Disorders. 2012 ; Vol. 12.

@article{19d8e262633e409ebc433762aa9079ba,

title = "Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial",

author = "A. Tomaschitz and A. Fahrleitner-Pammer and B. Pieske and N. Verheyen and K. Amrein and E. Ritz and K. Kienreich and J.H. Horina and A. Schmidt and E. Kraigher-Krainer and C. Colantonio and A. Meinitzer and S. Pilz",

year = "2012",

doi = "10.1186/1472-6823-12-19",

language = "Undefined/Unknown",

volume = "12",

journal = "BMC Endocrine Disorders",

issn = "1472-6823",

publisher = "BioMed Central",

}

Tomaschitz, A, Fahrleitner-Pammer, A, Pieske, B, Verheyen, N, Amrein, K, Ritz, E, Kienreich, K, Horina, JH, Schmidt, A, Kraigher-Krainer, E, Colantonio, C, Meinitzer, A & Pilz, S 2012, 'Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial', BMC Endocrine Disorders, vol. 12, 19. https://doi.org/10.1186/1472-6823-12-19

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial. / Tomaschitz, A.; Fahrleitner-Pammer, A.; Pieske, B.; Verheyen, N.; Amrein, K.; Ritz, E.; Kienreich, K.; Horina, J.H.; Schmidt, A.; Kraigher-Krainer, E.; Colantonio, C.; Meinitzer, A.; Pilz, S.

In: BMC Endocrine Disorders, Vol. 12, 19, 2012.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial

AU - Tomaschitz, A.

AU - Fahrleitner-Pammer, A.

AU - Pieske, B.

AU - Verheyen, N.

AU - Amrein, K.

AU - Ritz, E.

AU - Kienreich, K.

AU - Horina, J.H.

AU - Schmidt, A.

AU - Kraigher-Krainer, E.

AU - Colantonio, C.

AU - Meinitzer, A.

AU - Pilz, S.

PY - 2012

Y1 - 2012

U2 - 10.1186/1472-6823-12-19

DO - 10.1186/1472-6823-12-19

M3 - Article

C2 - 22974443

VL - 12

JO - BMC Endocrine Disorders

JF - BMC Endocrine Disorders

SN - 1472-6823

M1 - 19

ER -